.jpg)
.png)
All
If you have any questions or comments please fill out the form below or you can contact the National Lipid Association office directly: National Lipid Association c/o Compass Management... more
Dr. Don P. Wilson, a Fellow of the National Lipid Association, began his career with the National Lipid Association (NLA) in 2006. Dr. Wilson received his medical degree from the University of Mississippi and completed his internship and pediatric residency training at Baylor College of Medicine in... more
This Expert Clinical Review highlights the importance of a collaborative approach to the management of dyslipidemia and other cardiometabolic risk factors, including improved diagnosis and treatment, enhanced access to facilitation of lifestyle interventions, the optimization of pharmacotherapy,... more
The NLA held a consensus conference in January 2011 to bring together experts on inflammatory markers and advanced lipoprotein testing for the generation of an NLA statement of clinical guidance regarding the utility of various biomarkers. The panel reviewed apolipoprotein B (Apo B), C-reactive... more
.field.field-name-field-embargo.field-type-datetime.field-label-hidden, .field.field-name-field-rating.field-type-fivestar.field-label-inline.clearfix, .links { display: none } .body_table li, .head_table li, .body_table p, .head_table p { line-height: 20px; } .body_table a, .... more
The NLA is excited about the 2014 American Heart Association (AHA) Scientific Sessions (Nov. 15-19, Chicago). This is the premier meeting exploring all of the latest news and science related to heart and vascular disease, and we’ll be on-site engaging in conversations with thought leaders and... more
Hello fellow NLA members, Happy New Year! I hope everyone had a restful and happy holiday season. I look forward to celebrating the many incredible projects the NLA is executing in 2023, one being this SWLA/PLA LipidSpin. I hope you walk away after reading this with inspiration in your heart and... more
Muscle symptoms in patients on statin therapy are prevalent and offer a complicated differential for providers to entertain. Symptoms range from relatively mild aches and pains to severe and debilitating weakness and pain. Statins are taken by more than 25 million patients across the globe and have... more
The National Lipid Association has opened the nomination window for a position on the NLA Board of Directors or Chapter Board of Directors through Saturday, January 15, 2022, at 5:00 PM ET. NLA BOARD POSITIONS INCLUDE: President-Elect Treasurer/Secretary... more
International Collaborations The NLA is pleased to announce our organizational alliance with a new international liaison, the Polish Lipid Association and other new organization. Formal Collaboration Criteria More... more